Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, featuring promising developments throughout different professional medical and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA gives a safer, more responsible alternate for therapeutic